In the quarter ended December 31, 2025 (Q3 FY26), Tatva Chintan reported consolidated net profit of \u20b915.17 crore, marking an increase of more than 10,700% compared with \u20b90.14 crore in the quarter ended December 2024. Revenue for the period expanded 52.9% year-on-year to \u20b9131.33 crore from \u20b985.90 crore previously. Operating profit margins also improved, with operating margin rising to approximately 19.4%, up from 18.2% in the prior year quarter.<\/p>\n\n\n\n
<\/p>\n\n\n\n
Tatva Chintan Pharma Chem is a Gujarat-based specialty chemicals manufacturer, producing a portfolio of Phase Transfer Catalysts (PTCs), Structure Directing Agents (SDAs), electrolyte salts for batteries, and pharmaceutical and agrochemical intermediates. The company operates world-class facilities at Ankleshwar and Dahej in Gujarat, serving diverse end-markets including chemicals, pharmaceuticals, agrochemicals, and energy storage.<\/p>\n\n\n\n
SDAs and PTCs form core product lines, with the firm recognised as one of the largest producers of structure directing agents globally and a leading supplier in India. Robust research & development capabilities and a diversified product mix support its market positioning.<\/p>\n\n\n\n
The Q3 FY26 figures follow a strong Q2 FY26 performance, where the firm returned to profitability after earlier losses. In Q2 FY26 (ended September 30, 2025), Tatva Chintan reported revenue of \u20b9124.52 crore and net profit of \u20b99.92 crore, up significantly on both sequential and year-ago bases.<\/p>\n\n\n\n
Earlier in FY25, Q4 and the March 2025 quarter had shown weak profitability, including an 89% decline in net profit in Q4 FY25 relative to the prior year, reflecting cyclical pressures in specialty chemicals. The Q3 FY26 results indicate continued recovery momentum from that downturn.<\/p>\n\n\n\n
There were no announced mergers, acquisitions, or major divestitures linked to the Q3 FY26 results. The company\u2019s recent strategic actions have focused on capacity expansions, export orders, and leveraging niche product demand rather than inorganic growth. In mid-2025, the company received a notable export order of USD 3.555 million for specialty chemical supplies, supporting global revenue streams.<\/p>\n\n\n\n
Equity analysts tracking the specialty chemicals space noted Tatva Chintan\u2019s improved operating leverage, growing export traction, and successful turnaround from previous quarters as drivers for improved earnings.<\/p>\n\n\n\n
Management has not provided explicit forward guidance for FY27 but commentary suggests focus on ramp-up of existing capacities, scaling high-margin products, and strengthening global customer engagements. Given the recovery in earnings and broader industrial demand trends in specialty chemicals, the company is positioned for steady growth if demand conditions persist.<\/p>\n\n\n\n
Tatva Chintan\u2019s latest quarterly results reflect a meaningful rebound in profitability and revenue, supported by operational efficiencies and demand recovery in specialty chemical segments. While past volatility underscores the cyclical challenges in the sector, the Q3 FY26 performance marks a clear improvement trajectory compared with prior periods.<\/p>\n\n\n\n
<\/p>\n","protected":false},"excerpt":{"rendered":"
In the quarter ended December 31, 2025 (Q3 FY26), Tatva Chintan reported consolidated net profit of \u20b915.17 crore, marking an increase of more than 10,700% compared with \u20b90.14 crore in the quarter ended December 2024. Revenue for the period expanded 52.9% year-on-year to \u20b9131.33 crore from \u20b985.90 crore previously. Operating profit margins also improved, with […]<\/p>\n","protected":false},"author":2395,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5747,1941],"tags":[10162],"class_list":["post-175164","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare-stocks","category-stock-analysis","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":160824,"url":"https:\/\/alphastreet.com\/india\/tatva-chintan-pharma-chem-ltd-q4fy24-43-fall-in-profits\/","url_meta":{"origin":175164,"position":0},"title":"Tatva Chintan Pharma Chem Ltd Q4FY24; 43% fall in Profits","author":"Chirag Gupta","date":"May 3, 2024","format":false,"excerpt":"Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals Financial Results: Tatva Chintan Pharma Chem Ltd reported Revenues for Q4FY24 of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-24.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-24.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-24.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-24.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-24.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-24.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":155667,"url":"https:\/\/alphastreet.com\/india\/tatva-chintan-pharma-chem-ltd-q2fy24-9-rise-in-profits\/","url_meta":{"origin":175164,"position":1},"title":"Tatva Chintan Pharma Chem Ltd Q2FY24; 9% rise in Profits","author":"Chirag Gupta","date":"November 2, 2023","format":false,"excerpt":"Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals Financial Results: Tatva Chintan Pharma Chem Ltd reported Revenues for Q2FY24 of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-25.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-25.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-25.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-25.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-25.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/11\/image-25.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159943,"url":"https:\/\/alphastreet.com\/india\/tatva-chintan-pharma-chem-ltd-q3fy24-70-fall-in-profits\/","url_meta":{"origin":175164,"position":2},"title":"Tatva Chintan Pharma Chem Ltd Q3FY24; 70% fall in Profits","author":"Chirag Gupta","date":"March 18, 2024","format":false,"excerpt":"Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals Financial Results: Tatva Chintan Pharma Chem Ltd reported Revenues for Q3FY24 of\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-177.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-177.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-177.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-177.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-177.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-177.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151199,"url":"https:\/\/alphastreet.com\/india\/tatva-chintan-pharma-chem-ltd-q1fy24-3-fall-in-profits\/","url_meta":{"origin":175164,"position":3},"title":"Tatva Chintan Pharma Chem Ltd Q1FY24; 3% fall in Profits","author":"Chirag Gupta","date":"August 4, 2023","format":false,"excerpt":"Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals Financial Results: Tatva Chintan Pharma Chem Ltd reported Revenues for Q1FY24 of\u2026","rel":"","context":"In "Agricultural Products"","block_context":{"text":"Agricultural Products","link":"https:\/\/alphastreet.com\/india\/category\/agricultural-products\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-174.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-174.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-174.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-174.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-174.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-174.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":126442,"url":"https:\/\/alphastreet.com\/india\/tatva-chintan-pharma-chem-ltd-q3-fy22-earnings-conference-call-summary\/","url_meta":{"origin":175164,"position":4},"title":"Tatva Chintan Pharma Chem Ltd Q3 FY22 Earnings Conference Call Summary","author":"Praveen","date":"January 19, 2022","format":false,"excerpt":"https:\/\/www.youtube.com\/watch?v=L4XT8V39-C0 Key highlights from Tatva Chintan Pharma Chem Ltd (TATVA) Q3 FY22 Earnings Concall Management Update: TATVA said the company saw strong export growth and it has contributed nearly 80% of revenue on a nine month basis. The company also expects that its export revenue for FY22 will exceed the\u2026","rel":"","context":"In "Concall Highlights"","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":128588,"url":"https:\/\/alphastreet.com\/india\/tatva-chintan-pharma-chem-limited-q4-fy22-earnings-conference-call-insights\/","url_meta":{"origin":175164,"position":5},"title":"Tatva Chintan Pharma Chem Limited Q4 FY22 Earnings Conference Call Insights","author":"Praveen","date":"April 26, 2022","format":false,"excerpt":"https:\/\/youtu.be\/DTG434r6q74 Key highlights from Tatva Chintan Pharma Chem Limited (TATVA) Q4 FY22 Earnings Concall Management Update: For the first time, TATVA said, it crossed the revenue mark of INR400 crores, profit before tax of more than INR100 crores and exports revenue of INR300 crores. TATVA said it expects Q1 and\u2026","rel":"","context":"In "Concall Highlights"","block_context":{"text":"Concall Highlights","link":"https:\/\/alphastreet.com\/india\/category\/earnings-call-highlights\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/175164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2395"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=175164"}],"version-history":[{"count":2,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/175164\/revisions"}],"predecessor-version":[{"id":175281,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/175164\/revisions\/175281"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=175164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=175164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=175164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}